Alcidion Group (ASX:ALC) signed a AU$5.5 million annual recurring subscription license contract with the Hywel Dda University Health Board in Wales for the use of its Miya Precision platform, according to a Tuesday Australian bourse filing.
The university health board will use Miya Precision for patient flow, observations and assessments, as well as a Smartpage for clinical communications and tasking.
The contract will last over five years, with an option to further extend for seven years for a total contract value of AU$7.7 million.
The company's shares rose past 5% in recent trading on Tuesday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。